CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by shareholders' equity — page 2

Ranks 101–200 of 288 · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity
#CompanyShareholders' equityYoY15-year trend
101InsuletPODDUS$1.5B+25.1%
102Tilray BrandsTLRYUS$1.5B−44.6%
103EnovisENOVUS$1.5B−41.9%
104PenumbraPENUS$1.4B+24.0%
105Teladoc HealthTDOCUS$1.4B−7.1%
106Msa SafetyMSAUS$1.4B+19.6%
107Bright Horizons Family SolutionsBFAMUS$1.3B+4.8%
108Dentsply SironaXRAYUS$1.3B−31.1%
109Option Care HealthOPCHUS$1.3B−5.5%
110VeracyteVCYTUS$1.3B+11.4%
111Ardent HealthARDTUS$1.3B+13.8%
112Opko HealthOPKUS$1.3B−7.1%
113Beam TherapeuticsBEAMUS$1.2B+68.8%
114HUTCHMED (China)HCMHK$1.2B+62.9%
115Acadia PharmaceuticalsACADUS$1.2B+67.5%
116Krystal BiotechKRYSUS$1.2B+28.9%
117LivanovaLIVNGB$1.2B−9.1%
118InnovivaINVAUS$1.2B+69.7%
119Trulieve CannabisTRLVUS$1.1B−8.5%
120Sarepta TherapeuticsSRPTUS$1.1B−25.3%
121Fulgent GeneticsFLGTUS$1.1B−1.9%
122Cronos GroupCRONCA$1.1B+2.8%
123RadnetRDNTUS$1.1B+20.8%
124Lantheus HoldingsLNTHUS$1.1B+0.2%
125Addus HomecareADUSUS$1.1B+11.8%
126National HealthcareNHCUS$1.1B+9.0%
127Supernus PharmaceuticalsSUPNUS$1.1B+2.5%
128Integra LifesciencesIARTUS$1.0B−32.5%
129ConmedCNMDUS$1.0B+7.3%
130Ideaya BiosciencesIDYAUS$1.0B−3.4%
131Ligand PharmaceuticalsLGNDUS$1.0B+22.5%
132Legend BiotechLEGNUS$1.0B−3.7%
133ChemedCHEUS$979M−12.5%
134Oscar HealthOSCRUS$978M−3.5%
135Catalyst PharmaceuticalsCPRXUS$954M+31.1%
136Pacs GroupPACSUS$947M+33.4%
137HaemoneticsHAEUS$911M+0.5%
138Harmony BiosciencesHRMYUS$870M+32.0%
139National VisionEYEUS$870M+6.5%
140Pediatrix MedicalMDUS$866M+13.2%
141Nu Skin EnterprisesNUSUS$805M+23.6%
142SNDLSNDLCA$804M+2.1%
143Alnylam PharmaceuticalsALNYUS$789M+1,076.3%
144Amphastar PharmaceuticalsAMPHUS$789M+7.7%
145Inspire Medical SystemsINSPUS$781M+13.3%
146Avanos MedicalAVNSUS$778M−6.1%
147Curaleaf HoldingsCURLFUS$756M−12.2%
148Kindercare Learning CompaniesKLCUS$755M−12.6%
149OrganonOGNUS$752M+59.3%
150InsmedINSMUS$739M+158.9%
151Privia HealthPRVAUS$737M+16.1%
152Zai LabZLABCN$716M−14.9%
153Iovance BiotherapeuticsIOVAUS$699M−1.7%
154Pacira BiosciencesPCRXUS$693M−11.0%
155InmodeINMDIL$683M−2.9%
156GlaukosGKOSUS$656M−14.4%
157TG TherapeuticsTGTXUS$648M+191.4%
158Corcept TherapeuticsCORTUS$648M−4.7%
159XencorXNCRUS$636M−6.2%
160Arcus BiosciencesRCUSUS$631M+30.1%
161Sotera HealthSHCUS$606M+49.7%
162Madrigal PharmaceuticalsMDGLUS$603M−20.1%
163Aurinia PharmaceuticalsAUPHCA$581M+54.0%
164Caris Life SciencesCAIUS$577M+$3.1B
165Arrowhead PharmaceuticalsARWRUS$568M+980.9%
166Kiniksa Pharmaceuticals InternationalKNSAGB$568M+29.5%
167Fortrea HoldingsFTREUS$564M−58.6%
168Canopy GrowthCGCCA$546M+40.7%
169Hims & Hers HealthHIMSUS$541M+13.5%
170Ani PharmaceuticalsANIPUS$541M+33.9%
171Usana Health SciencesUSNAUS$533M+0.2%
172Emergent BiosolutionsEBSUS$523M+8.2%
173ProgynyPGNYUS$516M+22.3%
174Healthcare ServicesHCSGUS$510M+2.1%
175Ginkgo BioworksDNAUS$509M−29.0%
176CryoportCYRXUS$503M+25.1%
177AtricureATRCUS$492M+6.7%
178Ionis PharmaceuticalsIONSUS$489M−16.9%
179BilliontooneBLLNUS$480M+$732M
180Adma BiologicsADMAUS$477M+36.8%
181U S Physical TherapyUSPHUS$476M−2.6%
182Transmedics GroupTMDXUS$473M+107.0%
183Castle BiosciencesCSTLUS$471M+3.3%
184AmarinAMRNIE$459M−5.5%
185Medpace HoldingsMEDPUS$459M−44.4%
186Twist BioscienceTWSTUS$456M+0.0%
187Orthofix MedicalOFIXUS$450M−10.6%
188ArtivionAORTUS$448M+62.3%
189ArvinasARVNUS$434M−22.8%
190Ufp TechnologiesUFPTUS$424M+23.7%
191Telix PharmaceuticalsTLXAU$415M+17.7%
192CormedixCRMDUS$405M+378.8%
193Lemaitre VascularLMATUS$394M+16.7%
194Concentra Group Holdings ParentCONUS$393M+42.7%
195Rigel PharmaceuticalsRIGLUS$391M+11,806.3%
196TrupanionTRUPUS$384M+18.8%
197Immunocore HoldingsIMCRGB$381M+5.6%
198Pennant GroupPNTGUS$374M+20.0%
199Myriad GeneticsMYGNUS$368M−47.5%
200Warby ParkerWRBYUS$368M+8.1%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Largest companies by shareholders' equity →

By sector

By country